http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013515493-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2010-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013515493-A |
| titleOfInvention | Quantitative detection kit for K-ras mutation |
| abstract | The present invention relates to a kit for quantitative detection of K-ras mutation. Specifically, the present invention relates to a detection method and detection kit for a K-ras gene mutation related to the therapeutic effect of a molecularly targeted anticancer drug. In particular, the present invention relates to a fluorescence quantitative PCR detection method for detecting a mutation in the mutation hot spot region of the K-ras gene, a kit, and its application. The present invention can detect a mutation at a specific site of the K-ras gene and predict the therapeutic effect of an EGFR tyrosine kinase inhibitor as a molecular target antitumor drug, and further to a clinical individualized dosage plan for tumor patients. Provide guidance to them. [Selection] Figure 1 |
| priorityDate | 2009-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.